Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-10-24
2006-10-24
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S217090, C514S218000, C514S249000, C514S322000, C514S394000, C540S470000, C540S480000, C540S575000, C540S603000, C544S349000, C544S370000, C546S199000, C548S306100
Reexamination Certificate
active
07125877
ABSTRACT:
This invention provides compounds which are represented by a general formula [I][in which X stands for hydrogen or halogen; B stands for halogen, cyano or optionally fluorine-substituted lower alkyl; D stands for a 3–10 membered aliphatic nitrogen-containing heterocyclic group; R3, R4and R5may be same or different, and each stands for hydrogen, lower alkyl optionally having substituent group(s) and the like; and a is 0 or 1]. These compounds exhibit high affinity to nociceptin receptors and whereby inhibit actions of nociceptin, and are useful as an analgesic, antiobestic, agent for ameliorating brain function, treating agents for Alzheimer's disease and dementia, and therapeutic agents for schizophrenia, neurodegenerative diseases, depression, diabetes insipidus, polyuria, hypotension and the like.
REFERENCES:
patent: 0 254 322 (1988-01-01), None
patent: 0 370 381 (1990-05-01), None
patent: 0 963 987 (1999-12-01), None
patent: 0 970 957 (2000-01-01), None
patent: 99/36421 (1999-07-01), None
patent: 99/59997 (1999-11-01), None
patent: 00/14067 (2000-03-01), None
patent: 00/27815 (2000-05-01), None
Shinkai et al. J.Med. Chem. vol. 43, p. 4667-4677 (2000).
Yamada et al. British Journla of Pharmacology, vol. 135, p. 323-332 (2002).
Meunier et al., Nature, 377, 532-534 (1995).
Levine et al., Society for Neuroscience, 22, 455 (1996).
Stratford et al., NeuroReport, 8, 423-426 (1997).
Sandin et al., European Journal of Neuroscience, 9, 194-197 (1997).
Murphy et al., Neuroscience, 75(1), 1-4 (1996).
Mogil et al., Neuroscience, 75(2), 333-337 (1996).
Kapusta et al., Life Sciences, 60(1), PL 15-21 (1997).
Gamusel et al., Life Sciences, 60(8), PL 141-145 (1997).
Jenck et al., Proceedings of National Academy of Sciences, 94, 14854-14858 (1997).
Ueda et al., Neuroscience Letters, 237, 136-138 (1997).
Manabe et al., Nature, 394 577-581 (1998).
Malin et al., Psychopharmacology, 151, 344-350 (2000).
Ueda et al., The Journal of Neuroscience, 20 7640-7647 (2000),.
Köster et al., Proceedings of National Academy of Sciences, 96, 10444-10449 (1999).
Itoh Satoru
Kato Tetsuya
Kawamoto Hiroshi
Kobayashi Kensuke
Okamoto Osamu
Banyu Pharmaceutical Co. Ltd.
Bernhardt Emily
Wenderoth , Lind & Ponack, L.L.P.
LandOfFree
Benzimidazole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzimidazole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzimidazole derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3616696